Home › Multiple Myeloma › NCT05642884
Prehabilitation Feasibility Among Older Adults Undergoing Transplantation
Feasibility of a Prehabilitation Intervention Among Older Adults With Myeloma Receiving Autologous Stem Cell Transplant
Who can join
Ages 60 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Diagnosis of Multiple Myeloma * Scheduled for ASCT at UAB within 10 weeks of study enrollment * age at ASCT ≥60y Exclusion Criteria: * at high risk for impending pathologic fracture using Mirels score
About the study
This is a pilot feasibility trial among older adults (≥60y) scheduled to undergo Autologous Stem Cell transplantation at UAB. Participants will be randomized into either a prehabilitation program or an attention control group before their transplant. The primary outcomes will be feasibility and secondary outcomes include changes in physical function at the time of transplant and at 12 weeks follow up.
What is being tested
- Multi-modal Exercise Regimen (other)
- Dietary Guidelines (behavioral)
Sponsor: Noha Mohamed Sharafeldin · Participants: 30 · Started: Jul 10, 2023
Contact the study team
- Landon Martin, BS · Phone: 205-638-2120
- Noha Sharafeldin, MBBS PhD MSc · Phone: 2056382120
Official record on ClinicalTrials.gov — NCT05642884
Locations in the U.S.
| Alabama | Kirklin Clinic of UAB Hospital, Birmingham |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.